Literature DB >> 30371726

PVT1 affects EMT and cell proliferation and migration via regulating p21 in triple-negative breast cancer cells cultured with mature adipogenic medium.

Lingli Wang1, Ruirui Wang2, Zi Ye2, Yanyan Wang2, Xiao Li2, Weizhen Chen2, Mengna Zhang2, Cheguo Cai2.   

Abstract

Excessive adiposity has long been proved to be associated with greater incidence and mortality of breast cancer in post-menopausal women. However, the effects and underlying mechanisms of human adipocytes on breast cancer cells remain largely unknown. In recent years, several reports have revealed the oncogenic role of long non-coding RNA PVT1 in breast cancer. Here, we aimed to investigate the role and underlying mechanisms of PVT1 in triple-negative breast cancer (TNBC) cells cultured with mature adipogenic medium. At first, we successfully induced adipogenic differentiation from human adipose-derived mesenchymal stem cells and collected the mature adipogenic medium to mimic excessive adiposity. Our results demonstrated that the mature adipogenic medium promoted the epithelial-mesenchymal transition, enhanced the cell viability and migration potential of TNBC cells. In addition, we proved that mature adipogenic medium affected the PVT1 expression and inhibition of the PVT1 disturbed the role of mature adipogenic medium in TNBC cells. Finally, we illustrated that repression of p21 restored the phenotype caused by PVT1 knockdown in TNBC cells treated with mature adipogenic medium. Taken together, our results demonstrated that PVT1 affected the role of mature adipogenic medium in TNBC cells via modulating p21 expression.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30371726     DOI: 10.1093/abbs/gmy129

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  11 in total

1.  Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis.

Authors:  Daolin Ji; Li Hou; Chunyang Xie; Haonan Feng; Dongdong Bao; Yue Teng; Junhao Liu; Tiangang Cui; Xiuhong Wang; Yi Xu; Gang Tan
Journal:  J Oncol       Date:  2022-06-25       Impact factor: 4.501

Review 2.  Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer.

Authors:  Xue Hu; Qiang Zhang; Wanying Xing; Wan Wang
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

Review 3.  The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy.

Authors:  Nina-Naomi Kreis; Frank Louwen; Juping Yuan
Journal:  Cancers (Basel)       Date:  2019-08-21       Impact factor: 6.639

Review 4.  Roles and Mechanisms of the Long Noncoding RNAs in Cervical Cancer.

Authors:  Miguel Ángel Cáceres-Durán; Ândrea Ribeiro-Dos-Santos; Amanda Ferreira Vidal
Journal:  Int J Mol Sci       Date:  2020-12-21       Impact factor: 5.923

5.  Autophagy-Related Long Non-coding RNA Signature as Indicators for the Prognosis of Uveal Melanoma.

Authors:  Yi Cui; Mi Zheng; Jing Chen; Nuo Xu
Journal:  Front Genet       Date:  2021-04-01       Impact factor: 4.599

Review 6.  Oncogenic and Tumor Suppressive Components of the Cell Cycle in Breast Cancer Progression and Prognosis.

Authors:  Dharambir Kashyap; Vivek Kumar Garg; Elise N Sandberg; Neelam Goel; Anupam Bishayee
Journal:  Pharmaceutics       Date:  2021-04-17       Impact factor: 6.321

Review 7.  CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals.

Authors:  Alina Catalina Palcau; Valeria Canu; Sara Donzelli; Sabrina Strano; Claudio Pulito; Giovanni Blandino
Journal:  Mol Cancer       Date:  2022-01-28       Impact factor: 27.401

Review 8.  Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer.

Authors:  Weiping Yao; Shuang Li; Ruiqi Liu; Mingyun Jiang; Liang Gao; Yanwei Lu; Xiaodong Liang; Haibo Zhang
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

9.  Liquiritigenin decreases tumorigenesis by inhibiting DNMT activity and increasing BRCA1 transcriptional activity in triple-negative breast cancer.

Authors:  Fang Liang; Hao Zhang; Hui Gao; Duo Cheng; Nan Zhang; Jie Du; Junmin Yue; Peng Du; Beibei Zhao; Lu Yin
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-17

10.  Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin-Low Triple Negative Breast Cancer Cells.

Authors:  Fayola Levine; Olorunseun O Ogunwobi
Journal:  Cancers (Basel)       Date:  2021-03-02       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.